LY4060874

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4060874, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4060874 in Healthy Participants [Phase 1]